U.S. Bid To Extend Drug-Patent Term In TPP Nations Meets Resistance
This article was originally published in PharmAsia News
Executive Summary
The U.S. is maintaining its pressure on the other 11 Trans-Pacific Partnership nations to extend the term of patents and copyrights as part of the current negotiation round, but Brunei, Malaysia and Vietnam are resisting.